Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts General Hospital
Age
25–55
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Able to understand and sign informed consent.
Able to complete study and comply with study procedures.
Caucasian female ages 25-55.
Presence of photodamage and lentigines of II-III on the Glogau Photoaging
Must be willing to avoid laser and light treatments, treatments with filler, chemical peels, microdermabrasion, Botox or any other cosmetic treatment to the face during the duration of the study.
Must be willing to avoid changing topical moisturizers and cosmetics during the study.
Able to stop any alpha or beta hydroxy acids, topical retinol or retinoid derivatives, topical antioxidants, or any topical product that may interfere with the study 2 weeks prior to the study.
You may not be if
Cosmetic treatment of face, such as laser or light treatment, filler, Botox, microdermabrasion, or chemical peels 6 months prior to study or during study.
Current smoker.
Pregnant, nursing, or planning to become pregnant during study.
Currently taking drugs including oral retinoids or any other medication with a known clinically significant drug interaction with topical tretinoin.
Known hypersensitivity to retinoids. History of severe retinoid dermatitis.
History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study.
Concurrent participation in another clinical study or participation 30 days prior to enrollment that includes exposure to an investigational drug that would interfere with this study.
Any disease or condition which would interfere with study participation or unduly increase risk.
Presence of an electrically sensitive support system such as a pacemaker.
Known history of epilepsy.
Presence of metal implants or metal braces on teeth.
